These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 15340990)

  • 21. Smokeless tobacco use in the United States: the adult use of tobacco surveys.
    Novotny TE; Pierce JP; Fiore MC; Davis RM
    NCI Monogr; 1989; (8):25-8. PubMed ID: 2785647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health implications of smokeless tobacco use.
    Natl Inst Health Consens Dev Conf Consens Statement; 1986; 6(1):1-6. PubMed ID: 3523214
    [No Abstract]   [Full Text] [Related]  

  • 23. Reference moist smokeless tobacco-induced apoptosis in human monocytes/macrophages cell line MM6.
    Lombard C; Farthing D; Sun J; Fariss MW; McKallip RJ
    Int Immunopharmacol; 2010 Sep; 10(9):1029-40. PubMed ID: 20601189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Environmental tobacco smoke.
    National Toxicology Program
    Rep Carcinog; 2002; 10():234-6. PubMed ID: 15340989
    [No Abstract]   [Full Text] [Related]  

  • 25. Use of smokeless tobacco among adults--United States, 1991.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1993 Apr; 42(14):263-6. PubMed ID: 8459796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Health implications of smokeless tobacco use.
    Public Health Rep; 1986; 101(4):349-54. PubMed ID: 3090601
    [No Abstract]   [Full Text] [Related]  

  • 27. Tobacco smoking.
    Rep Carcinog; 2004; 11():III255-6. PubMed ID: 21089972
    [No Abstract]   [Full Text] [Related]  

  • 28. Chemical and toxicological characterization of commercial smokeless tobacco products available on the Canadian market.
    Rickert WS; Joza PJ; Trivedi AH; Momin RA; Wagstaff WG; Lauterbach JH
    Regul Toxicol Pharmacol; 2009 Mar; 53(2):121-33. PubMed ID: 19135498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydrazine and hydrazine sulfate.
    National Toxicology Program
    Rep Carcinog; 2011; 12():234-6. PubMed ID: 21852849
    [No Abstract]   [Full Text] [Related]  

  • 30. Supping with the devil? The role of law in promoting tobacco harm reduction using low nitrosamine smokeless tobacco products.
    Hall W; Gartner C
    Public Health; 2009 Mar; 123(3):287-91. PubMed ID: 19223052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Consensus conference. Health applications of smokeless tobacco use.
    JAMA; 1986 Feb; 255(8):1045-8. PubMed ID: 3945016
    [No Abstract]   [Full Text] [Related]  

  • 32. [Smokeless tobacco--a danger to health].
    Ainamo A
    Suom Hammaslaakarilehti; 1986 Sep; 33(15):925-30. PubMed ID: 3468571
    [No Abstract]   [Full Text] [Related]  

  • 33. Chronic effects of smokeless tobacco extract on rat liver histopathology and production of HSP-90.
    Bagchi M; Bagchi D; Adickes E; Stohs SJ
    J Environ Pathol Toxicol Oncol; 1995; 14(2):61-8. PubMed ID: 9372835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of smokeless tobacco use in the history and physical examination by primary healthcare providers.
    Talley B; Mary Gee R; Allen D; Marshall ES; Encinas K; Lim S
    J Am Acad Nurse Pract; 2011 Aug; 23(8):443-7. PubMed ID: 21790838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of smokeless tobacco in the United States: recent estimates from the current population survey.
    Marcus AC; Crane LA; Shopland DR; Lynn WR
    NCI Monogr; 1989; (8):17-23. PubMed ID: 2785646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NIH consensus development conference: health implications of smokeless tobacco.
    Am Pharm; 1986 Apr; NS26(4):18-20. PubMed ID: 3706124
    [No Abstract]   [Full Text] [Related]  

  • 37. Assessment of potential toxicity of a smokeless tobacco product (naswar) available on the Pakistani market.
    Zakiullah ; Saeed M; Muhammad N; Khan SA; Gul F; Khuda F; Humayun M; Khan H
    Tob Control; 2012 Jul; 21(4):396-401. PubMed ID: 21642445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Smokeless tobacco brand switching: a means to reduce toxicant exposure?
    Hatsukami DK; Ebbert JO; Anderson A; Lin H; Le C; Hecht SS
    Drug Alcohol Depend; 2007 Mar; 87(2-3):217-24. PubMed ID: 16996230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. National Institutes of Health consensus statement. Health implications of smokeless tobacco use. NIH Consensus Development Panel.
    Biomed Pharmacother; 1988; 42(2):93-8. PubMed ID: 3048429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Smokeless tobacco: health hazard on the rise.
    Gross JY; D'Alessandri R; Powell VL; Rodeheaver A
    South Med J; 1988 Sep; 81(9):1089-91. PubMed ID: 3420440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.